HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

T. Van Gorp, Isabelle Cadron, Evelyn Despierre, M.A. Daemen, Karin Leunen, F. Amant, D. Timmerman, B. De Moor, I. Vergote

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)863-870
JournalBritish Journal of Cancer
Volume104
Issue number5
DOIs
Publication statusPublished - 1 Mar 2011

Keywords

  • HE4
  • CA125
  • ovarian cancer
  • Risk of Ovarian Malignancy Algorithm

Cite this

Van Gorp, T., Cadron, I., Despierre, E., Daemen, M. A., Leunen, K., Amant, F., Timmerman, D., De Moor, B., & Vergote, I. (2011). HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. British Journal of Cancer, 104(5), 863-870. https://doi.org/10.1038/sj.bjc.6606092